These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6596165)

  • 1. In vitro combination effects of cefotetan with four aminoglycosides, piperacillin and mezlocillin on gram-positive and gram-negative nosocomial bacteria.
    Just HM; Becker C; Bassler M; Daschner FD
    Chemotherapy; 1984; 30(6):387-91. PubMed ID: 6596165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF; Wildfeuer A
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro comparison of cefotetan with five other cephalosporins against nosocomial pathogens.
    Daschner FD; Goerke C; Bassler M; Just M
    Chemotherapy; 1982; 28(5):351-4. PubMed ID: 6958416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro combination-effect of temocillin with ticarcillin and aminoglycosides on gram-negative and gram-positive bacteria.
    Just HM; Becker C; Gieringer J; Wenz A; Bassler M; Daschner F
    Drugs; 1985; 29 Suppl 5():74-7. PubMed ID: 4029031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro comparison of mezlocillin and piperacillin plus tobramycin or gentamicin versus 100 gram-negative nosocomial bloodstream isolates.
    Cabezudo I; Pfaller MA; Barrett M; Bale M; Wenzel RP
    Am J Infect Control; 1990 Aug; 18(4):250-6. PubMed ID: 2403216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination effect of piperacillin with four aminoglycosides on nonfermenting gram-negative bacteria.
    Daschner F; Langmaack H; Grehn M; Steffens A; Just M
    Chemotherapy; 1981; 27(1):39-43. PubMed ID: 6452252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unpredictable interactions between cefotetan and penicillins or aminoglycosides.
    Barry AL; Packer RR; Jones RN
    Diagn Microbiol Infect Dis; 1984 Sep; 2(4):347-51. PubMed ID: 6593145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefotetan: profile of in-vitro activity.
    Bauernfeind A
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():19-29. PubMed ID: 6601656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of cefotetan, other beta-lactams and netilmicin.
    Shah PM
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():73-8. PubMed ID: 6573326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dactimicin, a new aminoglycoside: in vitro activity, post-antibiotic effect and interaction with other antibiotics.
    Paglia P; Molinari G; Pesce A; Debbia EA
    Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):639-43. PubMed ID: 2506028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination effect of SCE-2787 and cefepime with aminoglycosides on nosocomial gram-negative bacteria.
    Hübner J; Hartung D; Kropec A; Daschner FD
    Infection; 1991; 19(3):186-9. PubMed ID: 1889877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity of cefpirome against bacteria isolated from hospitalized patients].
    Fernández A; Herran I; de Mier C; Marcenac FM
    Medicina (B Aires); 1989; 49(4):373-8. PubMed ID: 2487748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination effect of azthreonam with four aminoglycosides on nosocomial gram-positive cocci and non-fermenting gram-negative bacteria.
    Just HM; Phillips E; Bassler M; Daschner FD
    Eur J Clin Microbiol; 1982 Dec; 1(6):371-4. PubMed ID: 6891634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro combination effects of cefsulodin, moxalactam and cefoperazone with four aminoglycosides on nonfermenting nosocomial gram-negative bacteria.
    Daschner FD; Steffens A; Mählmann M; Metzger M
    Arzneimittelforschung; 1982; 32(5):531-3. PubMed ID: 6213241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative in-vitro activity of cefotetan against anaerobic bacteria.
    Watt B; Brown FV
    J Antimicrob Chemother; 1985 Jun; 15(6):671-7. PubMed ID: 3861604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination effect of ceftriaxone with four aminoglycosides on nonfermenting gram-negative bacteria.
    Just HM; Beckert A; Bassler M; Daschner FD
    Chemotherapy; 1982; 28(5):397-401. PubMed ID: 6291869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro bactericidal effect of cefotetan-aminoside combinations].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1988 May; 36(5):361-5. PubMed ID: 3043329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Susceptibility of gram-negative bacterial isolates to six beta-lactam and two aminoglycoside antibiotics at our university hospital].
    Tanabe T; Kobayashi T; Yoshida S; Mizuguchi Y
    J UOEH; 1988 Sep; 10(3):297-303. PubMed ID: 3175388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibacterial activity of mezlocillin against gram-negative and gram-positive bacteria from clinical isolates].
    Ravizzola G; Foresti I; Minelli F
    G Ital Chemioter; 1985; 32(2):277-80. PubMed ID: 3833562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.